- Home
- MPU vs BEAT Comparison
MPU vs BEAT Comparison
Compare MPU & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MPU | BEAT |
|---|---|---|
| Founded | 1989 | 2015 |
| Country | Singapore | United States |
| Employees | N/A | 16 |
| Industry | Transportation Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.6M | 54.2M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | MPU | BEAT |
|---|---|---|
| Price | $0.85 | $1.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.75 |
| AVG Volume (30 Days) | 55.8K | ★ 804.6K |
| Earning Date | 03-09-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $260.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.57 | $0.54 |
| 52 Week High | $4.44 | $4.00 |
Technical Indicators
Market Signals| Indicator | MPU | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 47.14 | 34.24 |
| Support Level | $0.77 | $0.91 |
| Resistance Level | $1.00 | $1.35 |
| Average True Range (ATR) | 0.06 | 0.12 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 54.73 | 4.54 |
Price Performance
Historical ComparisonAbout MPU Mega Matrix Corp.
Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.